Accuvest Global Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,938
| Closed | -$529K | – | 119 |
|
|
2023
Q3 | $529K | Buy |
15,938
+2,698
| +20% | +$95.4K | 0.29% | 62 |
|
|
2023
Q2 | $486K | Buy |
13,240
+3,520
| +36% | +$137K | 0.25% | 78 |
|
|
2023
Q1 | $397K | Sell |
9,720
-16,234
| -63% | -$701K | 0.18% | 84 |
|
|
2022
Q4 | $1.33M | Buy |
25,954
+12,960
| +100% | +$621K | 0.44% | 51 |
|
|
2022
Q3 | $569K | Buy |
12,994
+1,848
| +17% | +$89.8K | 0.39% | 54 |
|
|
2022
Q2 | $584K | Sell |
11,146
-690
| -6% | -$35.2K | 0.38% | 54 |
|
|
2022
Q1 | $613K | Buy |
11,836
+1,395
| +13% | +$72.4K | 0.31% | 61 |
|
|
2021
Q4 | $617K | Buy |
10,441
+905
| +9% | +$44.8K | 0.27% | 61 |
|
|
2021
Q3 | $410K | Buy |
9,536
+517
| +6% | +$22.9K | 0.19% | 73 |
|
|
2021
Q2 | $353K | Buy |
9,019
+1,615
| +22% | +$62.8K | 0.18% | 69 |
|
|
2021
Q1 | $268K | Buy |
+7,404
| New | +$263K | 0.14% | 79 |
|
|
2020
Q2 | – | Sell |
-346
| Closed | -$11K | – | 59 |
|
|
2020
Q1 | $11K | Buy |
+346
| New | +$11.8K | 0.03% | 40 |
|
|
2019
Q1 | – | Sell |
-27,267
| Closed | -$1.13M | – | 127 |
|
|
2018
Q4 | $1.13M | Buy |
27,267
+1,946
| +8% | +$80.8K | 0.59% | 33 |
|
|
2018
Q3 | $1.06M | Buy |
25,321
+14,145
| +127% | +$545K | 0.39% | 43 |
|
|
2018
Q2 | $385K | Buy |
11,176
+11,012
| +6,715% | +$376K | 0.15% | 104 |
|
|
2018
Q1 | $6K | Hold |
164
| – | – | ﹤0.01% | 85 |
|
|
2017
Q4 | $6K | Hold |
164
| – | – | ﹤0.01% | 75 |
|
|
2017
Q3 | $6K | Sell |
164
-16,635
| -99% | -$535K | 0.01% | 61 |
|
|
2017
Q2 | $535K | Buy |
+16,799
| New | +$530K | 0.18% | 56 |
|
|
2015
Q1 | – | Sell |
-16,421
| Closed | -$485K | – | 86 |
|
|
2014
Q4 | $485K | Buy |
+16,421
| New | +$471K | 0.1% | 80 |
|